758 related articles for article (PubMed ID: 8639067)
21. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
[TBL] [Abstract][Full Text] [Related]
22. Reduction in temporal N-acetylaspartate and creatine (or choline) ratio in temporal lobe epilepsy: does this 1H-magnetic resonance spectroscopy finding mean poor seizure control?
Mendes-Ribeiro JA; Soares R; Simões-Ribeiro F; Guimarães ML
J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):518-22. PubMed ID: 9771777
[TBL] [Abstract][Full Text] [Related]
23. Magnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis.
Wang H; Tan L; Wang HF; Liu Y; Yin RH; Wang WY; Chang XL; Jiang T; Yu JT
J Alzheimers Dis; 2015; 46(4):1049-70. PubMed ID: 26402632
[TBL] [Abstract][Full Text] [Related]
24. Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging.
Husted CA; Goodin DS; Hugg JW; Maudsley AA; Tsuruda JS; de Bie SH; Fein G; Matson GB; Weiner MW
Ann Neurol; 1994 Aug; 36(2):157-65. PubMed ID: 8053651
[TBL] [Abstract][Full Text] [Related]
25. Quantitative short echo time proton magnetic resonance spectroscopic imaging study of malformations of cortical development causing epilepsy.
Woermann FG; McLean MA; Bartlett PA; Barker GJ; Duncan JS
Brain; 2001 Feb; 124(Pt 2):427-36. PubMed ID: 11157569
[TBL] [Abstract][Full Text] [Related]
26. Effects of Alzheimer disease on fronto-parietal brain N-acetyl aspartate and myo-inositol using magnetic resonance spectroscopic imaging.
Zhu X; Schuff N; Kornak J; Soher B; Yaffe K; Kramer JH; Ezekiel F; Miller BL; Jagust WJ; Weiner MW
Alzheimer Dis Assoc Disord; 2006; 20(2):77-85. PubMed ID: 16772742
[TBL] [Abstract][Full Text] [Related]
27. Neurochemical correlates of cognitive dysfunction in patients with leukoaraiosis: a proton magnetic resonance spectroscopy study.
Wang S; Yuan J; Guo X; Peng P; Gu H; Niu S; Fregni F; Chen AC; Hu W
Neurol Res; 2012 Dec; 34(10):989-97. PubMed ID: 23146302
[TBL] [Abstract][Full Text] [Related]
28. Replicability of proton MR spectroscopic imaging findings in mild traumatic brain injury: Implications for clinical applications.
Chen AM; Gerhalter T; Dehkharghani S; Peralta R; Gajdošík M; Gajdošík M; Tordjman M; Zabludovsky J; Sheriff S; Ahn S; Babb JS; Bushnik T; Zarate A; Silver JM; Im BS; Wall SP; Madelin G; Kirov II
Neuroimage Clin; 2023; 37():103325. PubMed ID: 36724732
[TBL] [Abstract][Full Text] [Related]
29. Reduced NAA in the thalamus and altered membrane and glial metabolism in schizophrenic patients detected by 1H-MRS and tissue segmentation.
Auer DP; Wilke M; Grabner A; Heidenreich JO; Bronisch T; Wetter TC
Schizophr Res; 2001 Oct; 52(1-2):87-99. PubMed ID: 11595395
[TBL] [Abstract][Full Text] [Related]
30. [Cerebral metabolism in patients with cognitive disorders: a combined MRS and PET study].
Khomenko YG; Kataeva GV; Bogdan AA; Chernysheva EM; Susin DS
Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(1):51-58. PubMed ID: 30778031
[TBL] [Abstract][Full Text] [Related]
31. In vivo quantitative proton MRSI study of brain development from childhood to adolescence.
Horská A; Kaufmann WE; Brant LJ; Naidu S; Harris JC; Barker PB
J Magn Reson Imaging; 2002 Feb; 15(2):137-43. PubMed ID: 11836768
[TBL] [Abstract][Full Text] [Related]
32. Common pattern of cortical pathology in childhood-onset and adult-onset schizophrenia as identified by proton magnetic resonance spectroscopic imaging.
Bertolino A; Kumra S; Callicott JH; Mattay VS; Lestz RM; Jacobsen L; Barnett IS; Duyn JH; Frank JA; Rapoport JL; Weinberger DR
Am J Psychiatry; 1998 Oct; 155(10):1376-83. PubMed ID: 9766769
[TBL] [Abstract][Full Text] [Related]
33. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
Wang Z; Zhao C; Yu L; Zhou W; Li K
Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
[TBL] [Abstract][Full Text] [Related]
34. 1H-MR spectroscopy metabolite levels correlate with executive function in vascular cognitive impairment.
Gasparovic C; Prestopnik J; Thompson J; Taheri S; Huisa B; Schrader R; Adair JC; Rosenberg GA
J Neurol Neurosurg Psychiatry; 2013 Jul; 84(7):715-21. PubMed ID: 23418212
[TBL] [Abstract][Full Text] [Related]
35. Chemical pathology in brain white matter of recently detoxified alcoholics: a 1H magnetic resonance spectroscopy investigation of alcohol-associated frontal lobe injury.
Schweinsburg BC; Taylor MJ; Alhassoon OM; Videen JS; Brown GG; Patterson TL; Berger F; Grant I
Alcohol Clin Exp Res; 2001 Jun; 25(6):924-34. PubMed ID: 11410730
[TBL] [Abstract][Full Text] [Related]
36. Brain metabolite concentration and dementia severity in Alzheimer's disease: a (1)H MRS study.
Huang W; Alexander GE; Chang L; Shetty HU; Krasuski JS; Rapoport SI; Schapiro MB
Neurology; 2001 Aug; 57(4):626-32. PubMed ID: 11524470
[TBL] [Abstract][Full Text] [Related]
37. Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study.
Nordahl TE; Salo R; Natsuaki Y; Galloway GP; Waters C; Moore CD; Kile S; Buonocore MH
Arch Gen Psychiatry; 2005 Apr; 62(4):444-52. PubMed ID: 15809412
[TBL] [Abstract][Full Text] [Related]
38. N-acetylaspartate/creatine and choline/creatine ratios in the thalami, insular cortex and white matter as markers of hypertension and cognitive impairment in the elderly.
Ben Salem D; Walker PM; Bejot Y; Aho SL; Tavernier B; Rouaud O; Ricolfi F; Brunotte F
Hypertens Res; 2008 Oct; 31(10):1851-7. PubMed ID: 19015591
[TBL] [Abstract][Full Text] [Related]
39. Factor analysis of proton MR spectroscopic imaging data in HIV infection: metabolite-derived factors help identify infection and dementia.
Mohamed MA; Lentz MR; Lee V; Halpern EF; Sacktor N; Selnes O; Barker PB; Pomper MG
Radiology; 2010 Feb; 254(2):577-86. PubMed ID: 20093528
[TBL] [Abstract][Full Text] [Related]
40. [1H-MR spectroscopic imaging in patients with clinically diagnosed Alzheimer's disease].
Block W; Träber F; Kuhl CK; Fric M; Keller E; Lamerichs R; Rink H; Möller HJ; Schild HH
Rofo; 1995 Sep; 163(3):230-7. PubMed ID: 7548870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
